deferoxamine has been researched along with eye in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, R; Prabhu, P; Yaqoob, M | 1 |
| Apostoli, P; De Maria, G; Feller, P; Maiorca, R; Mombelloni, S; Movilli, E; Ravelli, M; Scaroni, P; Sciuto, G; Valotti, C | 1 |
| Borgna-Pignatti, C; Franchin, S; Gelmi, C; Tacchini, M; Trimarchi, F | 1 |
| Marumo, F; Sato, N; Takahashi, Y; Umetani, N | 1 |
| Gerkowicz, K; Prost, M | 2 |
| de Veber, LL; Orton, RB; Sulh, HM | 1 |
| Boelaert, JR; de Locht, M | 1 |
| Dekker, AW; Keunen, JE; Marx, JJ; Neijt, JP; Nortier, JW; Ros, FE; van Asbeck, BS; Voest, EE | 1 |
| Davis, BA; Porter, JB | 1 |
| Lischka, K; Luksch, H; Weigel, S; Yan, J | 1 |
1 review(s) available for deferoxamine and eye
| Article | Year |
|---|---|
Results of long term iron chelation treatment with deferoxamine.
Topics: Deferoxamine; Ear, Inner; Endocrine System Diseases; Eye; Heart Diseases; History, 20th Century; Humans; Infusions, Intravenous; Iron; Iron Chelating Agents; Iron Overload; Thalassemia; Time Factors | 2002 |
1 trial(s) available for deferoxamine and eye
| Article | Year |
|---|---|
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Eye; Female; Ferric Compounds; Humans; Iron; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sorbitol; Tumor Cells, Cultured | 1993 |
9 other study(ies) available for deferoxamine and eye
| Article | Year |
|---|---|
Comment on "Irreversible ocular toxicity from single challenge dose of desferrioxamine" by C. Bene et al.
Topics: Aluminum; Deferoxamine; Eye; Humans; Renal Dialysis | 1991 |
Acute visual disorders in patients on regular dialysis given desferrioxamine as a test.
Topics: Aged; Aluminum; Deferoxamine; Eye; Female; Humans; Male; Middle Aged; Ocular Physiological Phenomena; Optic Nerve; Renal Dialysis; Vision Disorders; Visual Acuity | 1990 |
Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major.
Topics: Adolescent; Adult; Child; Deferoxamine; Electroretinography; Evoked Potentials, Visual; Eye; Humans; Iron; Siderosis; Thalassemia | 1988 |
Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Calcitriol; Calcium; Deafness; Deferoxamine; Eye; Humans; Renal Dialysis; Uremia | 1987 |
[Therapeutical procedures for iron foreign bodies in the orbit].
Topics: Animals; Deferoxamine; Eye; Eye Foreign Bodies; Iron; Orbit; Rabbits; Siderosis | 1987 |
Studies on the use of desferrioxamine in experimental ocular siderosis produced by extrabulbar administration of iron.
Topics: Animals; Deferoxamine; Eye; Eye Diseases; Eye Foreign Bodies; Iron; Rabbits; Siderosis | 1985 |
Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy.
Topics: Child, Preschool; Deferoxamine; Ear; Eye; Female; Hearing Loss, Sensorineural; Humans; Injections, Subcutaneous; Optic Nerve Diseases; Thalassemia; Vision Disorders | 1985 |
Side-effects of desferrioxamine in dialysis patients.
Topics: Bacterial Infections; Brain Diseases; Deferoxamine; Eye; Hearing Loss, Sensorineural; Humans; Iron; Mycoses; Renal Dialysis | 1993 |
Effects of early eye removal on the morphology of a multisensory neuron in the chicken optic tectum.
Topics: Animals; Calbindins; Chick Embryo; Deferoxamine; Dextrans; Eye; Functional Laterality; Gene Expression Regulation, Developmental; In Vitro Techniques; Neuronal Plasticity; Sensory Deprivation; Sensory Receptor Cells; Superior Colliculi | 2018 |